期刊文献+

骨肉瘤化疗临床意义和方案实施 被引量:7

下载PDF
导出
摘要 骨肉瘤是最常见的原发性骨的恶性肿瘤,是高度恶性的间叶组织肿瘤,好发于10~20岁的青少年。骨肉瘤在局部呈侵袭性生长并且易发生转移,历史上,截肢是治疗骨肉瘤的标准方法,用这种方法治疗只有10%~20%的患者能够长期存活,大部分患者在2a内死于肺转移。85%~90%的患者就诊时已存在临床上不能发现的微转移灶,肺是最常见的转移部位,约占90%。骨肉瘤患者中,超过50%的病灶位于膝关节,截肢治疗给患者带来严重的肢体功能障碍。
作者 张清 牛晓辉
机构地区 北京积水潭医院
出处 《山东医药》 CAS 北大核心 2011年第40期48-50,共3页 Shandong Medical Journal
  • 相关文献

参考文献19

  • 1Bacci G,Longhi A,Fagioli F,et al.Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities:27 year experience at Rizzoli Institute,Italy[J].Eur J Cancer,2005,41 (18):2836-2845.
  • 2Link MP,Goorin AM,Miser AW,et al.The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity[J].N Engl J Med,1986,314(25):1600-1606.
  • 3Link MP,Goorin AM,Horowitz M,et al.Adjuvant chemotherapy of high-grade osteosarcoma of the extremity.Updated results of the Multi-Institutional Osteosarcoma Study[J].Clin Orthop Rel Res,1991,(270):8-14.
  • 4Eilber F,Giuliano A,Eckardt J,et al.Adjuvant chemotherapy for osteosarcoma:a randomized prospective trial[J].J Clin Oncol,1987,5(1):21-26.
  • 5Bielack SS,Kempf-Bielack B,Delling G,et al.Prognostic factors in high-grade osteosarcoma of the extremities or trunk:an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols[J].J Clin Oncol,2002,20(3):776-790.
  • 6Ferrari S,Smeland S,Mercuri M,et al.Neoadjuvant chemotherapy with high-dose Ifosfamide,high-dose methotrexate,cisplatin,and doxorubicin for patients with localized osteosarcoma of the extremity:a joint study by the Italian and Scandinavian Sarcoma Groups[J].J Clin Oncol,2005,23(34):8845-8852.
  • 7Bacci G,Ferrari S,Longhi A,et al.High dose ifosfamide in combination with high dose methotrexate,adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma:preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study[J].J Chemother,2002,14(2):198-206.
  • 8Meyers PA,Schwartz CL,Krailo M,et al.Osteosarcoma:a ran domized,prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin,doxorubicin,and high-dose methotrexate[J].J Clin Oncol,2005,23(9):2004-2011.
  • 9Eselgrim M,Grunert H,Kühne T,et al.Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials[J].Pediatr Blood Cancer,2006,47 (1):42-50.
  • 10Lewis IJ,Weeden S,Machin D,et al.Received dose and dose-in tensity of chemotherapy and outcome in nonmetastatic extremity os teosarcoma.European Osteosarcoma Intergroup[J].J Clin Oncol,2000,18(24):4028-4037.

二级参考文献3

共引文献53

同被引文献74

  • 1李秀贺,章萍.阿拓莫兰治疗儿童大剂量甲氨蝶呤化疗性肝损害临床观察[J].天津医科大学学报,2004,10(3):423-424. 被引量:2
  • 2李秀贺,张平.硫普罗宁防治大剂量甲氨蝶呤致儿童肝损害临床观察[J].药物不良反应杂志,2004,6(5):303-305. 被引量:10
  • 3林丽珠,周京旭,张恩欣,黄海福.恩度联合含培美曲塞方案治疗复发耐药骨肉瘤2例[J].中国肿瘤临床,2007,34(20):1197-1199. 被引量:15
  • 4张志才,邵增务.骨肉瘤新辅助化疗研究进展[J].现代肿瘤医学,2007,15(10):1515-1518. 被引量:5
  • 5Picci P. Osteosarcoma (osteogenic sarcoma)D]. OrphanetJ Rare Dis, 2007, 2:6.
  • 6Bentzen SM. Prognostic factor studies in oncology: osteosarcoma as a clinical example[J]. IntJ Radiat Oncol Biol Phys, 2001,49(2): 513-51 8.
  • 7Yu W, Tang L, Lin F, et a/. Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma[J]. IntJ Oncol, 2014, 44(4):1091-1098.
  • 8Pfannschmidt J, Egerer G, Bischof M, etal. Surgical intervention for pulmonary metastases[J]. Dtsch Arztebl Int, 201 2, 109(40):645-651.
  • 9Gootin AM, Harris MB, Bernstein M, et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial[J].JClin Oncol, 2002, 20(2):426-433.
  • 10Kager L, Zoubek A, P6tschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols[J]. J C/in Oncol, 2003,21 (10):2011-201 8.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部